Erectile dysfunction and coronary atherothrombosis in diabetic patients: pathophysiology, clinical features and treatment
- PMID: 16509813
- DOI: 10.1586/14779072.4.2.173
Erectile dysfunction and coronary atherothrombosis in diabetic patients: pathophysiology, clinical features and treatment
Abstract
The current review reports recent data available in the literature on the prevalence of erectile dysfunction and the association of erectile dysfunction with overt and silent coronary artery disease in patients with diabetes mellitus. The mechanisms by which erectile dysfunction is associated with coronary artery disease and potential clinical implications of this association have been extensively analysed. In particular, the role of endothelial dysfunction in the pathophysiology of erectile dysfunction and the potential clinical usefulness of erectile dysfunction to identify diabetic patients with silent coronary artery disease have been outlined. Finally, recent guidelines on the treatment of erectile dysfunction with phosphodiesterase-5 inhibitors in diabetic patients with and without coronary artery disease have been reported and discussed.
Similar articles
-
Erectile dysfunction therapy in special populations and applications: coronary artery disease.Am J Cardiol. 2005 Dec 26;96(12B):62M-66M. doi: 10.1016/j.amjcard.2005.10.008. Epub 2005 Dec 7. Am J Cardiol. 2005. PMID: 16387570 Review.
-
Erectile dysfunction in patients with coronary artery disease.Int J Impot Res. 2005 May-Jun;17(3):209-15. doi: 10.1038/sj.ijir.3901309. Int J Impot Res. 2005. PMID: 15729374 Review.
-
Erectile dysfunction as a predictor of cardiovascular events and death in diabetic patients with angiographically proven asymptomatic coronary artery disease: a potential protective role for statins and 5-phosphodiesterase inhibitors.J Am Coll Cardiol. 2008 May 27;51(21):2040-4. doi: 10.1016/j.jacc.2007.10.069. J Am Coll Cardiol. 2008. PMID: 18498958
-
[Erectile dysfunction and phosphodiesterase type 5 inhibitors].Rev Med Brux. 2003 Jun;24(3):169-75. Rev Med Brux. 2003. PMID: 12891884 Review. French.
-
[Some aspects of erectile dysfunction pathogenesis and treatment in patients with obesity].Ter Arkh. 2006;78(2):92-4. Ter Arkh. 2006. PMID: 16613108 Review. Russian. No abstract available.
Cited by
-
Intracavernous Injection of Platelet-Rich Plasma Therapy Enhances Erectile Function and Decreases the Mortality Rate in Streptozotocin-Induced Diabetic Rats.Int J Mol Sci. 2022 Mar 10;23(6):3017. doi: 10.3390/ijms23063017. Int J Mol Sci. 2022. PMID: 35328437 Free PMC article.
-
Traditional Chinese medicine on treating diabetic mellitus erectile dysfunction: Protocol for a systematic review and meta-analysis.Medicine (Baltimore). 2019 Mar;98(13):e14928. doi: 10.1097/MD.0000000000014928. Medicine (Baltimore). 2019. PMID: 30921189 Free PMC article.
-
Erectile dysfunction as a predictor of asymptomatic coronary artery disease in elderly men with type 2 diabetes.J Geriatr Cardiol. 2016 Sep;13(6):552-6. doi: 10.11909/j.issn.1671-5411.2016.06.011. J Geriatr Cardiol. 2016. PMID: 27582774 Free PMC article. No abstract available.
-
Phosphodiesterase type-5 inhibitor use in type 2 diabetes is associated with a reduction in all-cause mortality.Heart. 2016 Nov 1;102(21):1750-1756. doi: 10.1136/heartjnl-2015-309223. Epub 2016 Jul 26. Heart. 2016. PMID: 27465053 Free PMC article.
-
Erectile dysfunction in stroke patients: a multifactorial problem with important psychosocial consequences.Int Urol Nephrol. 2008;40(4):1113-4. doi: 10.1007/s11255-008-9425-9. Epub 2008 Aug 6. Int Urol Nephrol. 2008. PMID: 18683073 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical